CEO 2024 Year in Review

Date published: January 13, 2025 9:00 am PST

CEO Punit Dhillon discusses Skye’s accomplishments in 2024 and the execution plans for 2025, in particular announcing data from its Phase 2 study of nimacimab for weight loss.